Austin Health

Title
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
Publication Date
2021-02
Author(s)
Bhabha, Friyana K
McCormack, Christopher
Wells, Jillian
Campbell, Belinda A
Newland, Kate
Lade, Stephen
Buelens, Odette
Joske, David
Shortt, Jake
Mapp, Sally
Radeski, Dejan
Hertzberg, Mark
Khot, Amit
Van Der Weyden, Carrie
Khoo, Christine
Hawkes, Eliza A
Prince, H Miles
Subject
Sézary syndrome
clinical practices statement
cutaneous T-cell lymphoma
management
mycosis fungoides
Type of document
Journal Article
OrcId
0000-0002-6067-4694
DOI
10.1111/ajd.13467
Abstract
Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sézary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with helpful patient resources and access to support groups, can be found at the following (http://www.australasianlymphomaalliance.org.au).
Link
Citation
The Australasian Journal of Dermatology 2021; 62(1): e8-e18
Jornal Title
The Australasian Journal of Dermatology

Files:

NameSizeformatDescriptionLink